YOUNGER ADULTS ALSO REQUIRE KIDNEY SUPPORTIVE CARE

L PURTELL1,2,3, A BONNER1,2,3, HG HEALY2,3,4
1Faculty of Health, Queensland University Of Technology, Brisbane, Australia, 2Kidney Health Service, Metro North Hospital & Health Service, Brisbane, Australia, 3Chronic Kidney Disease Centre of Research Excellence, Brisbane, Australia, 4Kidney Research Laboratory, Queensland Institute of Medical Research, Brisbane, Australia

Aim: To describe the characteristics of younger people with end-stage kidney disease (ESKD) requiring kidney supportive care (KSC).
Background: Advanced age is a predictor of poor outcomes for people with ESKD; consequently, supportive care pathways tend to be geared towards older people considering withdrawal from kidney replacement therapy (KRT) or being managed conservatively. However, a discrete group of younger people with ESKD also need support around decision-making conflicts, symptom distress and psychosocial problems. We describe the characteristics of a young cohort of people with ESKD who were referred to a multidisciplinary KSC program from 2016–2018.
Methods: We extracted data from clinical records and compared gender, indigenous status, treatment modality and reason for referral to KSC between those ≤50 years of age at time of referral and those >50 using chi square tests (p<0.05 considered statistically significant).
Results: Of 260 people referred to KSC, the median age was 73.5 years; however, 12% were ≤50 (range 27–50). Gender splits were similar with 43% female ≤50 and 47% >50 (p=n.s.). Aboriginal and Torres Strait Islander (A&TSI) people were overrepresented in ≤50 (20% vs. 3% >50; p<0.0001). Those ≤50 were more likely to be receiving (or on a transition pathway to) KRT at referral than those >50 (100% vs. 48%, respectively; p<0.0001), and more likely to have been referred for symptom management (73% vs. 42%, respectively; p=001).
Conclusions: Although most people referred for KSC are elderly, younger people with ESKD are also accessing KSC for the management of symptoms while receiving KRT; this is disproportionately frequent in A&TSI people. Symptom relief in ESKD is emerging as a gap in care that requires a specialised skill set.


Biography:
Dr Louise Purtell is a postgraduate research fellow in the Faculty of Health, Queensland University of Technology and a member of the Chronic Kidney Disease Centre of Research Excellence.

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

© 2015 - 2016 Conference Design Pty Ltd